Xistab

Xistab (cytisinicline) is an oral medication used for smoking cessation support. It helps reduce nicotine cravings and withdrawal symptoms during quitting. This non-nicotine therapy is designed for adults seeking to stop smoking. A clinically studied option for tobacco dependence.

Xistab is used to help adults quit smoking by reducing nicotine cravings and withdrawal symptoms. It is designed as a short-term therapy to support smoking cessation efforts. People looking to stop smoking may find this medication helpful in managing the challenges of nicotine dependence. It is not a nicotine replacement therapy.

Xistab may help reduce the urge to smoke by acting on nicotine receptors in the brain. Users often report feeling less irritable or anxious when cravings arise. Some individuals experience mild side effects like nausea or sleep disturbances. Effects vary by person and are part of the body’s adjustment to reduced nicotine dependence.

Store Xistab at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if you are allergic to cytisinicline or any ingredients. Consult a healthcare provider if you have a history of seizures or mental health conditions. Follow the prescribed duration to avoid potential risks.

Xistab may interact with certain medications, including CYP2D6 enzyme inhibitors or inducers. Alcohol and sedatives may enhance drowsiness when combined with Xistab. Always inform your healthcare provider about all medications and supplements you are taking. Avoid combining with other smoking cessation products unless directed.